Haibo Zhang

1.9k total citations · 1 hit paper
63 papers, 1.1k citations indexed

About

Haibo Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Haibo Zhang has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Haibo Zhang's work include Lung Cancer Treatments and Mutations (15 papers), Acupuncture Treatment Research Studies (11 papers) and Cancer Genomics and Diagnostics (8 papers). Haibo Zhang is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Acupuncture Treatment Research Studies (11 papers) and Cancer Genomics and Diagnostics (8 papers). Haibo Zhang collaborates with scholars based in China, Australia and United States. Haibo Zhang's co-authors include Yi‐Hong Liu, Chuanjian Lu, Brian H. May, Anthony Lin Zhang, Xinfeng Guo, Charlie Changli Xue, Jean‐Louis Vincent, Yihan He, Jun J. Mao and Daniel De Backer and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Brain Research.

In The Last Decade

Haibo Zhang

55 papers receiving 1.0k citations

Hit Papers

Clinical Evidence for Association of Acupuncture and Acup... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Evidence for Association of Acupuncture and Acupressure With Improved Cancer Pain
    2019 252 citations Yihan He, Xinfeng Guo et al. profile →

Peers

Haibo Zhang
Ziwen Wang China
Christina Wood United States
Qiong Li China
Huiqin Li China
Meiqi Zhou China
Gang Zhao China
Yu‐Chuen Huang Taiwan
A. Hage United States
Kehua Zhou China
Eric Chun‐Pu Chu United States
Ziwen Wang China
Haibo Zhang
Citations per year, relative to Haibo Zhang Haibo Zhang (= 1×) peers Ziwen Wang

Countries citing papers authored by Haibo Zhang

Since Specialization
Citations

This map shows the geographic impact of Haibo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Zhang more than expected).

Fields of papers citing papers by Haibo Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Zhang. The network helps show where Haibo Zhang may publish in the future.

Co-authorship network of co-authors of Haibo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Zhang. A scholar is included among the top collaborators of Haibo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Zhang. Haibo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Haibo, et al.. (2024). Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy. Cancer Immunology Immunotherapy. 74(1). 1–1. 1 indexed citations
4.
5.
Zhou, Qing, Lin Wu, Bo Jiang, et al.. (2023). Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1b/2 clinical trial results using CD73 as a potential predictive biomarker.. Journal of Clinical Oncology. 41(16_suppl). 2570–2570. 4 indexed citations
6.
Zhu, Yan-juan, et al.. (2022). Lung cancer organoids, a promising model still with long way to go. Critical Reviews in Oncology/Hematology. 171. 103610–103610. 22 indexed citations
7.
Zhang, Haibo, et al.. (2022). The molecular pathogenesis of triptolide-induced hepatotoxicity. Frontiers in Pharmacology. 13. 979307–979307. 22 indexed citations
8.
Yu, Yaya, et al.. (2021). Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models. Evidence-based Complementary and Alternative Medicine. 2021. 1–14. 5 indexed citations
9.
He, Yihan, Brian H. May, Anthony Lin Zhang, et al.. (2019). Acupuncture for cancer pain: protocol for a pilot pragmatic randomised controlled trial. BMJ Open. 9(7). e025564–e025564. 6 indexed citations
10.
May, Brian H., Anthony Lin Zhang, Xinfeng Guo, et al.. (2018). Acupuncture and Related Therapies for Treatment of Postoperative Ileus in Colorectal Cancer: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2018(1). 3178472–3178472. 53 indexed citations
11.
Zheng, Fang, Qing Tang, Xiaohua Zheng, et al.. (2018). Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer. Experimental & Molecular Medicine. 50(9). 1–14. 38 indexed citations
12.
He, Yihan, Yi‐Hong Liu, Brian H. May, et al.. (2017). Effectiveness of acupuncture for cancer pain: protocol for an umbrella review and meta-analyses of controlled trials. BMJ Open. 7(12). e018494–e018494. 16 indexed citations
13.
Azhar, Ahsan, Sriram Yennurajalingam, Haibo Zhang, et al.. (2017). Timing of Referral and Characteristics of Uninsured, Medicaid, and Insured Patients Referred to the Outpatient Supportive Care Center at a Comprehensive Cancer Center. Journal of Pain and Symptom Management. 55(3). 973–978. 8 indexed citations
14.
Zhu, Yan-juan, Haibo Zhang, Yi‐Hong Liu, et al.. (2017). Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer. Oncology Letters. 14(1). 655–664. 7 indexed citations
15.
Zhu, Yan-juan, Haibo Zhang, Yi‐Hong Liu, et al.. (2017). Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients. Lung Cancer. 109. 124–127. 28 indexed citations
16.
Zhang, Wen, Renjie Hu, Lei Zhang, Hongbin Zhu, & Haibo Zhang. (2016). Outcomes of surgical repair of pediatric coronary artery fistulas. Journal of Thoracic and Cardiovascular Surgery. 152(4). 1123–1130.e1. 14 indexed citations
17.
Zhang, Haibo, et al.. (2016). Acupuncture for Pain Management in Cancer: A Systematic Review and Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2016(1). 1720239–1720239. 81 indexed citations
18.
Li, Gaoyang, et al.. (2006). Preliminary Results of Combination Therapy with Chinese Herbs and Vinorelbine in Elderly Advanced Non-Small Cell Lung Cancer. 3(2). 72–77. 2 indexed citations
19.
Backer, Daniel De, Jacques Créteur, Haibo Zhang, Michelle Norrenberg, & Jean‐Louis Vincent. (1997). Lactate Production by the Lungs in Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 156(4). 1099–1104. 134 indexed citations
20.
Spapen, Herbert, et al.. (1997). TREATMENT WITH A PLATELET-ACTIVATING FACTOR ANTAGONIST HAS LITTLE PROTECTIVE EFFECTS DURING ENDOTOXIC SHOCK IN THE DOG. Shock. 8(3). 200–206. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziwen Wang Breakdown of academic impact, for papers by Christina Wood Breakdown of academic impact, for papers by Qiong Li Breakdown of academic impact, for papers by Huiqin Li Breakdown of academic impact, for papers by Meiqi Zhou Breakdown of academic impact, for papers by Gang Zhao Breakdown of academic impact, for papers by Yu‐Chuen Huang Breakdown of academic impact, for papers by A. Hage Breakdown of academic impact, for papers by Kehua Zhou Breakdown of academic impact, for papers by Eric Chun‐Pu Chu
Rankless by CCL
2026